Results 191 to 200 of about 966,197 (400)

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, André Lourenço, Adelino Leite‐Moreira, Inês Falcão‐Pires, Sarah Werner, Holger Thiele, Simon Sedej, Antje Schauer, Volker Adams   +10 more
wiley   +1 more source

Natriuretic peptides and chronic heart failure in arterial hypertension patients

Кардиоваскулярная терапия и профилактика, 2007
The review is devoted to natriuretic peptides perspectives in left ventricular (LV) systolic and diastolic dysfunction assessment and LV hypertrophy diagnostics in arterial hypertension (AH) patients. The data describing possible antihypertensive therapy
Yu. A. Vasuyk, A. B. Khadzegova, S. V. Ivanova, I. M. Amirbegishvili, N. I. Gerasimova, E. N. Yushchuk, O. V. Krikunova, V. G. Bitsuev   +7 more
doaj  

Effects of antiserum against alpha-rat atrial natriuretic peptide in anesthetized rats. [PDF]

, 1987
Akira Sasaki, Osamu Kida, Johji Kato, Shigeru Nakamura, Kenji Kodama, Atsuro Miyata, Kenji Kangawa, H. Matsuo, Kenjiro Tanaka   +8 more
openalex   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Natriuretic Peptides and Need for Reliable Tool to Assess Pulmonary Congestion for Treatment Monitoring in Heart Failure. [PDF]

J Community Hosp Intern Med Perspect, 2023
Bhatia MS, Attri R, Sharda SC, Swarup P, Garg A.   +4 more
europepmc   +1 more source

Plasma Atrial Natriuretic Peptide in States of Altered Thyroid Function.

, 1988
TOHRU YAMAJI, Miyuki Ishibashi, Fumimaro Takaku, Fujio Sato, Kyuzi Kamoi   +4 more
openalex   +2 more sources

Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides

European Journal of Heart Failure, 2017
E. D’Elia, A. Iacovoni, M. Vaduganathan, F. Lorini, S. Perlini, M. Senni   +5 more
semanticscholar   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. [PDF]

Yale J Biol Med, 2023
Samad M, Malempati S, Restini CBA.
europepmc   +1 more source

Atrial Natriuretic Peptide Infusion in Chronic Heart Failure in the Rat

, 1989
Masahiro Kohzuki, G P Hodsman, Richard W. Harrison, Patrick Western, Colin I. Johnston   +4 more
openalex   +1 more source